Article Details
Retrieved on: 2021-09-07 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NYSE: RCOR), an early-stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for devastating cardiovascular and central ...
Article found on: www.valdostadailytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here